REDUCEd RECURRENCE for better patient outcomes
Enhancing Bladder Cancer Detection with Vision AI
Reducing Recurrence through Earlier Detection
Bladder cancer is one of the most expensive forms of cancer to treat due to its high rate of recurrence - over 50% of new patients will experience recurrence within the first two years after diagnosis.
Vesica AI is revolutionizing bladder cancer detection with state-of-the-art AI technology designed to enhance diagnostic accuracy and reduce cancer recurrence rates, providing healthcare professionals with critical support in identifying difficult-to-spot lesions.
Vesica AI is revolutionizing bladder cancer detection with state-of-the-art AI technology designed to enhance diagnostic accuracy and reduce cancer recurrence rates, providing healthcare professionals with critical support in identifying difficult-to-spot lesions.